Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-25-200819
Filing Date
2025-09-11
Accepted
2025-09-11 09:10:25
Documents
4
Group Members
BAUSCH HEALTH AMERICAS, INC.BHC LYON MERGER SUB, INC.

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d947540dsctota.htm SC TO-T/A 23875
2 EX-99.(A)(5)(C) d947540dex99a5c.htm EX-99.(A)(5)(C) 13167
3 GRAPHIC g947540g0911023045581.jpg GRAPHIC 3737
4 GRAPHIC g947540g0911023045784.jpg GRAPHIC 2456
  Complete submission text file 0001193125-25-200819.txt   47922
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filed by) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Subject) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-60499 | Film No.: 251307326
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)